Cor Vasa 2023, 65(6):843-847 | DOI: 10.33678/cor.2023.067

DNA methylation and coronary artery disease: Brief summary of the main findings

Asma Amrani-Midouna, b, Nadia Laredjc, Farouk Boukerchec
a Biotechnology Department, Faculty of Sciences of Nature and Life, University of Oran 1 Ahmed Benbella, Algeria
b Medical Biochemistry and Molecular Biology Laboratory, Faculty of Medicine, University of Oran 1 Ahmed Benbella, Algeria
c Cardiology Department, Faculty of Medicine, University Hospital Center of Oran, University of Oran 1 Ahmed Benbella, Algeria

Cardiovascular disease (CVD) and more specifically coronary artery disease (CAD) continue to be the leading cause of mortality worldwide. Many genetic factors have been identified to contribute to the risk of develop-ing CAD. However, the etiology and pathophysiology of complex diseases such as CAD are driven not only by genetic factors but also by the interaction between genetic and environmental factors. Therefore, research-ers are now exploring the epigenome, a biological interface at which genetics and the environment can interact. DNA methylation is the main epigenetic form of gene regulation, and it is increasingly recognized to play an important role in cardiovascular disease. Thus, we aim in this short review to summarize the main recent studies on the eventual contribution of DNA methylation status in the onset of CAD.

Keywords: Cardiovascular disease, Coronary artery disease, DNA methylation, Epigenetics

Received: August 10, 2023; Revised: August 10, 2023; Accepted: September 5, 2023; Prepublished online: June 2, 2012; Published: December 22, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Amrani-Midoun A, Laredj N, Boukerche F. DNA methylation and coronary artery disease: Brief summary of the main findings. Cor Vasa. 2023;65(6):843-847. doi: 10.33678/cor.2023.067.
Download citation

References

  1. Roth GA, Mensah GA, Johnson CO, et al. Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study. J Am Coll Cardiol 2020;76:2982-3021. Go to original source... Go to PubMed...
  2. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352:1685-1695. Go to original source... Go to PubMed...
  3. Frostegård J, Ulfgren AK, Nyberg P, et al. Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis 1999;45:33-43. Go to original source... Go to PubMed...
  4. Longmore JM, et al. Oxford handbook of clinical medicine. Ninth edition. Oxford: Oxford University Press, 2014:902. Go to original source...
  5. Gertler MM, Garn SM, White PD. Young candidates for coronary heart disease. J Am Med Assoc 1951;147:621-625. Go to original source... Go to PubMed...
  6. Khera AV, Kathiresan S. Genetics of coronary artery disease: discovery, biology and clinical translation. Nat Rev Genet 2017;18:331-344. Go to original source... Go to PubMed...
  7. Duan L, Liu C, Hu J, et al. Epigenetic mechanisms in coronary artery disease: The current state and prospects. Trends Cardiovasc Med 2018;28:311-319. Go to original source... Go to PubMed...
  8. Mahmood A, et al. Drugs Resistance in Heart Diseases. In: Ahmed S, et al., eds. Biochemistry of Drug Resistance. Springer International Publishing, 2021:295-334. Go to original source...
  9. Stephens KE, Miaskowski CA, Levine JD, et al. Epigenetic regulation and measurement of epigenetic changes. Biol Res Nurs 2013;15:373-381. Go to original source... Go to PubMed...
  10. Shi Y, Zhang H, Huang S, et al. Epigenetic regulation in cardiovascular disease: mechanisms and advances in clinical trials. Signal Transduct Targeted Ther 2022;7:200. Go to original source... Go to PubMed...
  11. Xie S, Wang Z, Okano M, et al. Cloning, expression and chromosome locations of the human DNMT3 gene family. Gene 1999;236:87-95. Go to original source... Go to PubMed...
  12. Mortusewicz O, Schermelleh L, Walter J, et al. Recruitment of DNA methyltransferase I to DNA repair sites. Proc Natl Acad Sci U S A 2005;102:8905-8909. Go to original source... Go to PubMed...
  13. Reed ZE, Suderman MJ, Relton CL, et al. The association of DNA methylation with body mass index: distinguishing between predictors and biomarkers. Clin Epigenetics 2020;12:50. Go to original source... Go to PubMed...
  14. Hedman ÅK, Mendelson MM, Marioni RE, et al. Epigenetic Patterns in Blood Associated With Lipid Traits Predict Incident Coronary Heart Disease Events and Are Enriched for Results From Genome-Wide Association Studies. Circ Cardiovasc Genet 2017;10:e001487. Go to original source... Go to PubMed...
  15. Richard MA, Huan T, Ligthart S, et al. DNA Methylation Analysis Identifies Loci for Blood Pressure Regulation. Am J Hum Genet 2017;101:888-902. Go to original source... Go to PubMed...
  16. Wei L, Liu S, Su Z, et al. LINE-1 hypomethylation is associated with the risk of coronary heart disease in Chinese population. Arq Bras Cardiol 2014;102:481-488. Go to original source... Go to PubMed...
  17. Guarrera S, Fiorito G, Onland-Moret NC, et al. Gene-specific DNA methylation profiles and LINE-1 hypomethylation are associated with myocardial infarction risk. Clin Epigenetics 2015;7:133. Go to original source... Go to PubMed...
  18. Kim M, Long TI, Arakawa K, et al. DNA Methylation as a Biomarker for Cardiovascular Disease Risk. PLoS One 2010;5:e9692. Go to original source... Go to PubMed...
  19. Agha G, Mendelson MM, Ward-Caviness CK, et al. Blood Leukocyte DNA Methylation Predicts Risk of Future Myocardial Infarction and Coronary Heart Disease. Circulation 2019;140:645-657. Go to original source... Go to PubMed...
  20. Westerman K, Sebastiani P, Jacques P, et al. DNA methylation modules associate with incident cardiovascular disease and cumulative risk factor exposure. Clin Epigenetics 2019;11:142. Go to original source... Go to PubMed...
  21. Kennel PJ, Liao X, Saha A, et al. Impairment of Myocardial Glutamine Homeostasis Induced By Suppression of the Amino Acid Carrier SLC1A5 in Failing Myocardium. Circ Heart Fail 2019;12:e006336. Go to original source... Go to PubMed...
  22. Navas-Acien A, Domingo-Relloso A, Subedi P, et al. Blood DNA Methylation and Incident Coronary Heart Disease: Evidence From the Strong Heart Study. JAMA Cardiol 2021;6:1237-1246. Go to original source... Go to PubMed...
  23. Palou-Márquez G, Subirana I, Nonell L, et al. DNA methylation and gene expression integration in cardiovascular disease. Clin Epigenetics 2021;13:75. Go to original source... Go to PubMed...
  24. Luo X, Hu Y, Shen J, et al. Integrative analysis of DNA methylation and gene expression reveals key molecular signatures in acute myocardial infarction. Clin Epigenetics 2022;14:46. Go to original source... Go to PubMed...
  25. Jaiswal S, Natarajan P, Silver AJ, et al. Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease. N Engl J Med 2017;377:111-121. Go to original source... Go to PubMed...
  26. Yu J, Qiu Y, Yang J, et al. DNMT1-PPARgamma pathway in macrophages regulates chronic inflammation and atherosclerosis development in mice. Sci Rep 2016;6:30053. Go to original source... Go to PubMed...
  27. Kim J, Kim JY, Song KS, et al. Epigenetic changes in estrogen receptor beta gene in atherosclerotic cardiovascular tissues and in-vitro vascular senescence. Biochim Biophys Acta 2007;1772:72-80. Go to original source... Go to PubMed...
  28. Connelly JJ, Cherepanova OA, Doss JF, et al. Epigenetic regulation of COL15A1 in smooth muscle cell replicative aging and atherosclerosis. Hum Mol Genet 2013;22:5107-5120. Go to original source... Go to PubMed...
  29. Guay SP, Légaré C, Houde AA, et al. Acetylsalicylic acid, aging and coronary artery disease are associated with ABCA1 DNA methylation in men. Clin Epigenetics 2014;6:14. Go to original source... Go to PubMed...

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.





Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.